Recent studies show GLP-1s tied higher osteoporosis risk, with variations by diabetes status and weight changes in large patient datasets.

A new research study has shed light on potential side effects of GLP-1 drugs, including Wegovy and Ozempic. According to a ...

People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs. But diet and ...

About 4% of GLP-1 users developed osteoporosis, compared with a little over 3% of nonusers — an increased risk of about 30%. A related condition, osteomalacia, which involves the softening of the ...

New research suggests popular GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro may raise the risk of osteoporosis and gout. A large five-year study found slightly higher rates of bone ...

--Amgen today announced new data from a real-world study of nearly half of a million postmenopausal women with osteoporosis in the U.S. medicare program showing Prolia ® injection reduced fracture ...

Positive topline results demonstrate clinical similarity between AVT03 and the reference biologic, Prolia® (denosumab) Two additional studies comparing the pharmacokinetics, safety, and tolerability ...

REYKJAVIK, Iceland, July 02, 2024 (GLOBE NEWSWIRE) -- Alvotech, a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today ...